VC  Altitude Life Science Ventures

https://www.altitudelsv.com/





     Office Locations:

1014 Market St., Suite 200
Kirkland, WA 98033

 

Stages:

  • Early


 

Industries:

  • Consumer Products & Services
  • Food & Agriculture
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Altitude Life Science Ventures seeks opportunities to invest in early stage life science companies within markets with significant demand and growth potential. The scope of investment opportunities extends beyond prescription drugs to any commercial application of proprietary technology that originates from a key advance in biology or chemistry, including: Therapeutics / Diagnostics, Medical Devices, Aesthetic and Medical Dermatology, Drug Delivery Platforms, Industrial / Chemical Reactions, Optical Displays, Agriculture / Plant Microbiome, DNA Sequencing, and Pulmonary Delivery.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dave Maki Co-Founder
    Kristen Wong Associate

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      07/24/2017


      Effector Therapeutics


      CA


      $38,600,000


      Series C


     

    Portfolio companies include:


      Achaogen
        web link


      Arete Therapeutics
        web link


      BlackThorn Therapeutics
        web link


      Cambrios Technologies
        web link


      Constellation Pharmaceuticals
        web link


      Effector Therapeutics
        web link


      Ikaria
        web link


      Kythera
        web link


      Limerick Neurosciences
        web link


      Receptos
        web link


      Sienna Biopharmaceuticals
        web link


      Siluria Technologies
        web link


     

    Recent News: